US Stock MarketDetailed Quotes

CBRE CBRE Group

Watchlist

129.780
+1.140+0.89%

Close Jan 8 16:00 ET

129.780
0.0000.00%

Post 16:37 ET

39.72BMarket Cap42.00P/E (TTM)

CBRE Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CBRE Group Q4 2024 Estimates Date

Currency：USDFeb 13, 2025

	Estimate	YoY
Revenue	10.25B	+14.48%
EPS	2.09	+35.00%

Analyst Rating

Strong Buy

Jan 9, 2025

CBRE Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 8.795B	--
Feb 13, 2025	2024/Q4	-- / 10.246B	--
Oct 24, 2024	2024/Q3	9.036B / 8.801B	--
Jul 25, 2024	2024/Q2	8.391B / 8.314B	--
May 3, 2024	2024/Q1	7.935B / 7.950B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 8.795B--

Feb 13, 20252024/Q4-- / 10.246B--

Oct 24, 20242024/Q39.036B / 8.801B--

Jul 25, 20242024/Q28.391B / 8.314B--

May 3, 20242024/Q17.935B / 7.950B--

Unlock Free Earnings Estimates

Open Account

CBRE Group Earnings Reports

CBRE Group | 10-Q: Q3 2024 Earnings Report

Oct 24, 2024 07:23 ET

CBRE Group | 8-K: CBRE GROUP, INC. REPORTS FINANCIAL RESULTS FOR THIRD-QUARTER 2024

Oct 24, 2024 07:09 ET

CBRE Group | 10-Q: Q2 2024 Earnings Report

Jul 25, 2024 06:59 ET

CBRE Group | 8-K: CBRE GROUP, INC. REPORTS FINANCIAL RESULTS FOR SECOND-QUARTER 2024

Jul 25, 2024 06:54 ET

Trending US Stocks

Symbol Mini Chart % Chg

Collegium Pharmaceutical

Halozyme Therapeutics

Unlock the Full List

Analysis

Analyst Rating

Updated: Jan 9, 2025

Strong Buy

Buy
80.00%
Hold
20.00%
Sell
0.00%

Price Target

No Data